Last $115.84 USD
Change Today -0.09 / -0.08%
Volume 609.0K
WAT On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

waters corp (WAT) Key Developments

Waters Corporation Presents at Stifel Healthcare Conference 2014, Nov-18-2014 08:00 AM

Waters Corporation Presents at Stifel Healthcare Conference 2014, Nov-18-2014 08:00 AM. Venue: The Palace Hotel, 455 Madison Ave, New York, NY 10022, United States. Speakers: Eugene G. Cassis, Chief Financial Officer and Vice President, John Lynch, V.P., Investor Relations.

Waters Corporation Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 27, 2014; Provides earnings guidance for the fourth quarter and Full Year 2014

Waters Corporation announced unaudited consolidated earnings results for the third quarter and nine months ended September 27, 2014. For the quarter, the company announced net sales of $493,165,000 compared to $457,317,000 for the same period a year ago. Operating income was $138,713,000 compared to $119,069,000 for the same period a year ago. Income from operations before income taxes was $131,413,000 compared to $112,657,000 for the same period a year ago. Net income was $113,497,000 compared to $98,048,000 for the same period a year ago. Net income per diluted common share was $1.34 compared to $1.14 for the same period a year ago. Adjusted non-GAAP operating income was $141,629,000 compared to $124,435,000 for the same period a year ago. Adjusted non-GAAP net income was $116,792,000 compared to $102,798,000 for the same period a year ago. Adjusted non-GAAP EPS was $1.38 compared to $1.19 for the same period a year ago. For the nine months, the company announced net sales of $1,405,474,000 compared to $1,338,770,000 for the same period a year ago. Operating income was $345,869,000 compared to $341,166,000 for the same period a year ago. Income from operations before income taxes was $326,267,000 compared to $320,780,000 for the same period a year ago. Net income was $280,328,000 compared to $308,421,000 for the same period a year ago. Net income per diluted common share was $3.29 compared to $3.56 for the same period a year ago. Adjusted non-GAAP operating income was $368,444,000 compared to $355,291,000 for the same period a year ago. Adjusted non-GAAP net income was $299,283,000 compared to $289,760,000 for the same period a year ago. Adjusted non-GAAP EPS was $3.51 compared to $3.34 for the same period a year ago. The company expects full year operating tax rate to be around 14%. The company anticipates full year 2014 constant currency sales growth of about 5% and adjusted fully diluted earnings per share in the range of $5.34 to $5.44. These results assume the following: A modest full year currency translation headwind to sales of less than 1%; a negative currency impact to full year EPS of about 20% Non-GAAP earnings per fully diluted share within a range of $1.83 to $1.93 in the fourth quarter 2014.

Waters Corp Mulls Acquisitions

Waters Corporation (NYSE:WAT) is looking for acquisitions. Douglas Berthiaume, Chairman, President and Chief Executive Officer of Waters Corporation said, "On the M&A front and for the Waters division we continue to see opportunities to benefit our long-term initiatives in applications such as food safety testing, microbiology and clinical diagnostics by licensing and acquiring innovative technologies. For our TA division we will likely continue a consistent and focused business acquisition plan."

Waters Corporation Introduces Size Exclusion Chromatography (SEC) Columns for Protein-Based Biotherapeutics Analysis

Waters Corporation introduced new size exclusion chromatography (SEC) columns for the characterization of proteins. For use with Waters(R) Alliance(R) HPLC, Waters ACQUITY(R) UPLC(R) H-Class Systems and other HPLC/UHPLC instruments, the XBridge(R) Protein BEH SEC Columns deliver optimal throughput and resolution for size-based separations of protein-based biotherapeutics. The columns are immediately available from Waters worldwide. The XBridge Protein BEH SEC Columns are packed with 3.5 m particles and are available in either 200 or 450 Å pore sizes for analyzing proteins and other biomolecules ranging in molecular weight from 10,000 to 1,500,000 Da. The columns are designed to operate at higher flow rates and pressures than traditional silica-based SEC columns. These characteristics result in either increased sample throughput or, by using multiple columns in series, greater component resolution. Use of Waters diol-bonded, BEH Technology particles delivers outstanding column longevity and Waters proprietary manufacturing process ensures unmatched batch-to-batch and column-to-column consistency for reproducible results. These new offerings complement Waters ACQUITY Protein BEH SEC columns and provide laboratories with the ability to seamlessly transfer methods from UPLC to HPLC using columns containing particles differing only in their size. Each batch of XBridge Protein BEH SEC 200 and 450, 3.5 m material is extensively tested to ensure unmatched batch-to-batch consistency. Each column is shipped with a vial of either the BEH200 or BEH450 SEC Protein Standard Mixture for column and LC System benchmarking, method development, or troubleshooting. These standards are the same as those used for quality control testing of XBridge Protein BEH SEC batches. They may be used to verify the performance of each column upon receipt and to monitor their condition over time.

Waters Corporation, Q3 2014 Earnings Call, Oct 21, 2014

Waters Corporation, Q3 2014 Earnings Call, Oct 21, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WAT:US $115.84 USD -0.09

WAT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cintas Corp $71.92 USD 0.00
Hospira Inc $58.82 USD 0.00
Mettler-Toledo International Inc $293.54 USD +1.03
PerkinElmer Inc $45.33 USD +1.33
WR Grace & Co $95.96 USD +0.31
View Industry Companies
 

Industry Analysis

WAT

Industry Average

Valuation WAT Industry Range
Price/Earnings 23.4x
Price/Sales 4.9x
Price/Book 5.2x
Price/Cash Flow 22.3x
TEV/Sales 3.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WATERS CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.